Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

SHE:002864 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	-	1,102	823.44	419.3	382
Cash & Short-Term Investments	1,164	1,102	823.44	419.3	382
Cash Growth	5.64%	33.83%	96.38%	9.77%	7.66%
Accounts Receivable	-	476.42	538.41	446.38	402.75
Other Receivables	-	3.07	2.13	2.55	4.4
Receivables	-	479.49	540.54	448.93	407.15
Inventory	-	77.63	94.63	66.77	66.39
Other Current Assets	-	18.67	23.33	21.45	7.87
Total Current Assets	-	1,678	1,482	956.45	863.41
Property, Plant & Equipment	-	371.7	353.74	275.04	197.4
Long-Term Investments	-	9.71	9.89	-	-
Other Intangible Assets	-	52.76	54.9	56.33	57.77
Long-Term Deferred Tax Assets	-	7.22	16.63	20.2	16.44
Long-Term Deferred Charges	-	2.87	1.31	0.02	0.09
Other Long-Term Assets	-	2.96	12.36	22.13	27.43
Total Assets	-	2,125	1,931	1,330	1,163
Accounts Payable	-	91.43	121.67	66.01	58.81
Accrued Expenses	-	181.38	215.43	176.72	151.54
Short-Term Debt	-	100.34	150.46	87.2	48.24
Current Portion of Long-Term Debt	-	-	247.62	13	-
Current Portion of Leases	-	0.39	1.41	2.03	-
Current Income Taxes Payable	-	9.11	14.73	17.21	15.91
Current Unearned Revenue	-	5.53	13.26	4.7	2.41
Other Current Liabilities	-	92.23	138.11	70.69	67.26
Total Current Liabilities	-	480.41	902.68	437.55	344.18
Long-Term Debt	-	-	27.35	40.35	53.35
Long-Term Leases	-	2.11	0.33	1.32	-
Long-Term Unearned Revenue	-	91.25	52.83	41.4	27.53
Long-Term Deferred Tax Liabilities	-	-	-	2.35	1.83
Total Liabilities	-	573.76	983.18	522.97	426.89
Common Stock	-	106.28	86.71	86.67	86.67
Additional Paid-In Capital	-	817.78	259.43	271.67	271.3
Retained Earnings	-	640.06	548.96	463.19	382.85
Treasury Stock	-	-15.07	-15.07	-30.15	-20.05
Comprehensive Income & Other	-	-	49.62	-	-
Total Common Equity	1,607	1,549	929.65	791.38	720.78
Minority Interest	-	2.21	17.95	15.82	14.89
Shareholders' Equity	1,609	1,551	947.6	807.21	735.66
Total Liabilities & Equity	-	2,125	1,931	1,330	1,163
Total Debt	152.11	102.84	427.16	143.9	101.59
Net Cash (Debt)	1,012	999.18	396.28	275.41	280.41
Net Cash Growth	1.29%	152.14%	43.89%	-1.78%	-20.97%
Net Cash Per Share	9.68	10.22	4.58	3.22	3.26
Filing Date Shares Outstanding	102.2	105.15	95.8	85.54	85.95
Total Common Shares Outstanding	102.2	105.15	85.59	85.54	85.95
Working Capital	-	1,197	579.27	518.89	519.23
Book Value Per Share	15.05	14.73	10.86	9.25	8.39
Tangible Book Value	1,556	1,496	874.75	735.05	663.01
Tangible Book Value Per Share	14.56	14.23	10.22	8.59	7.71
Buildings	-	331.9	329.36	152.82	143.01
Machinery	-	134.72	125.41	60.38	51.53
Construction In Progress	-	29.31	3.85	152.18	84.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.